Skip to content
Twitter page opens in new windowLinkedin page opens in new windowInstagram page opens in new windowYouTube page opens in new window
[email protected]+61 3 9692 7222
PharmAust (PAA)
Cancer Therapeutics Research
PharmAust (PAA)
  • HOME
  • ABOUT
    • Board
    • Management
    • Corporate Directory
  • PIPELINES & TRIALS
    • Monepantel for Motor Neurone Disease
    • Publications
  • INVESTOR HUB
    • ASX Announcements
    • Annual Reports
    • Investor Presentations
    • Analyst Reports
    • Financial Reports
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Videos
    • Media
  • CONTACT
  • HOME
  • ABOUT
    • Board
    • Management
    • Corporate Directory
  • PIPELINES & TRIALS
    • Monepantel for Motor Neurone Disease
    • Publications
  • INVESTOR HUB
    • ASX Announcements
    • Annual Reports
    • Investor Presentations
    • Analyst Reports
    • Financial Reports
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Videos
    • Media
  • CONTACT

Author Archives: PharmAust

Share Holder Update

News & Announcements 2018By PharmAust31/07/2018

Top 20 Shareholders July 2018

Financial Reports 2018, News & Announcements 2018, Top 20 ShareholdersBy PharmAust13/07/2018

Top_Holders_Report (4)

Epichem Accreditation

News & Announcements 2018By PharmAust02/07/2018

180702_Epichem Accreditation

PharmAust biotech lab earns coveted accreditation

Articles In The NewsBy PharmAust02/07/2018

Becoming a Substantial Holder

News & Announcements 2018By PharmAust29/06/2018

180629_Becoming a Substantial Holder

Director’s Interest Part II

News & Announcements 2018By PharmAust27/06/2018

180627_Director's Interest Part II

Director’s Interest Part I

News & Announcements 2018By PharmAust27/06/2018

180627_Director's Interest Part I

Director’s Interest

News & Announcements 2018By PharmAust26/06/2018

180626_Director's Interest

Top 20 Shareholders June 2018

Financial Reports 2018, News & Announcements 2018, Top 20 ShareholdersBy PharmAust10/06/2018

Top 20 04.06.18

PharmAust biotech lab gets $1.6m contract extension

Articles In The NewsBy PharmAust08/06/2018
←1
234567891011121314151617181920212223242526272829
…3031323334…
3536373839404142434445464748495051
52→
MENU
  • Home
  • About Us
  • Pipeline & Trials
  • Investor Centre
  • Media
  • Contact Us
SUBSCRIBE TO OUR NEWSLETTER

PharmAust Follow

PharmAust is a clinical-stage biotech company focused on repurposing monepantel (MPL) for human neurodegenerative diseases ASX: $PAA FSE: $ECQ

PharmAust
pharmaust PharmAust @pharmaust ·
24 Jun

📸 Highlights from the MND Australia Global Day Event at Parliament House!

We teamed up with FightMND to raise awareness and fight for a future free of Motor Neurone Disease. 💙

#MNDAustralia #FightMND #MNDGlobalDay

Reply on Twitter 1805134834358210569 Retweet on Twitter 1805134834358210569 2 Like on Twitter 1805134834358210569 12 Twitter 1805134834358210569
Retweet on Twitter PharmAust Retweeted
stockheadau Stockhead @stockheadau ·
21 Jun

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.
#ASX @PharmAust

Reply on Twitter 1803984607676654065 Retweet on Twitter 1803984607676654065 1 Like on Twitter 1803984607676654065 3 Twitter 1803984607676654065
pharmaust PharmAust @pharmaust ·
21 Jun

Exciting news for our investors! 🎉 Check out the details of our latest capital raise here: https://investorhub.pharmaust.com/investment-offer/32. Thank you for your continued support! 🌟 #PharmAust

Reply on Twitter 1804030728956711230 Retweet on Twitter 1804030728956711230 2 Like on Twitter 1804030728956711230 7 Twitter 1804030728956711230
Load More

Copyright © 2024 PharmAust. All rights reserved.
nil

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top